We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
-2.53%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$44.3B
AUM Growth
+$548M
(+1.3%)
Cap. Flow
+$2.58B
Cap. Flow
% of AUM
5.82%
Top 10 Holdings %
Top 10 Hldgs %
27.39%
Holding
2,291
New
20
Increased
497
Reduced
1,558
Closed
209
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$224M |
| 2 |
Microsoft
MSFT
|
+$200M |
| 3 |
Eversource Energy
ES
|
+$180M |
| 4 |
Erie Indemnity
ERIE
|
+$178M |
| 5 |
Amazon
AMZN
|
+$173M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$51.8M |
| 2 |
Cardinal Health
CAH
|
+$45.2M |
| 3 |
Williams-Sonoma
WSM
|
+$44.3M |
| 4 |
Walmart Inc
WMT
|
+$43.9M |
| 5 |
IBM
IBM
|
+$35.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.93% |
| 2 | Consumer Staples | 10.3% |
| 3 | Consumer Discretionary | 10.1% |
| 4 | Financials | 9.92% |
| 5 | Industrials | 9.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RGLS
2026
DELISTED
Regulus Therapeutics
RGLS
| $23.9K | ﹤0.01% |
13,671
-4,114
| -23% | -$5.43K |
|
2027
BRC Inc
BRCC
$126M
| $23.9K | ﹤0.01% |
11,442
-3,444
| -23% | -$8.78K |
|
2028
Nerdy
NRDY
$107M
| $23.9K | ﹤0.01% |
16,822
-4,528
| -21% | -$7.62K |
|
2029
NN Inc
NNBR
$272M
| $22.8K | ﹤0.01% |
10,072
-3,030
| -23% | -$8.7K |
|
2030
SkinHealth Systems
SKIN
$94.9M
| $21.6K | ﹤0.01% |
16,111
-4,848
| -23% | -$7.39K |
|
2031
Stereotaxis
STXS
$129M
| $21.5K | ﹤0.01% |
12,232
-3,681
| -23% | -$7.84K |
|
2032
Fate Therapeutics
FATE
$281M
| $21.2K | ﹤0.01% |
26,811
-6,834
| -20% | -$8.38K |
|
2033
ProKidney
PROK
$308M
| $21.1K | ﹤0.01% |
24,099
-6,780
| -22% | -$9.41K |
|
|
MAPS
2034
DELISTED
WM TECHNOLOGY INC A
MAPS
| $21.1K | ﹤0.01% |
18,656
-5,615
| -23% | -$7.49K |
|
2035
Tango Therapeutics
TNGX
$4.34B
| $20.8K | ﹤0.01% |
15,205
-3,319
| -18% | -$8.15K |
|
2036
MacroGenics
MGNX
$235M
| $20.5K | ﹤0.01% |
16,137
-4,147
| -20% | -$10.8K |
|
2037
Pliant Therapeutics
PLRX
$67.5M
| $20.4K | ﹤0.01% |
15,080
-3,851
| -20% | -$23.4K |
|
2038
Zentalis Pharmaceuticals
ZNTL
$308M
| $19.7K | ﹤0.01% |
12,370
-3,724
| -23% | -$8.03K |
|
2039
Coherus Oncology
CHRS
$217M
| $19.6K | ﹤0.01% |
24,331
-7,004
| -22% | -$8.06K |
|
2040
Wheels Up
UP
$220M
| $19.6K | ﹤0.01% |
971
-292
| -23% | -$8.04K |
|
2041
Blink Charging
BLNK
$75.2M
| $19.1K | ﹤0.01% |
20,827
-6,268
| -23% | -$7.25K |
|
2042
Lexicon Pharmaceuticals
LXRX
$1.02B
| $19K | ﹤0.01% |
41,162
-8,298
| -17% | -$5.24K |
|
|
NOVA
2043
DELISTED
Sunnova Energy
NOVA
| $18.7K | ﹤0.01% |
50,208
-12,426
| -20% | -$23.9K |
|
2044
Atossa Therapeutics
ATOS
$22.9M
| $18.4K | ﹤0.01% |
1,825
-550
| -23% | -$6.68K |
|
2045
Lineage Cell Therapeutics
LCTX
$257M
| $17.6K | ﹤0.01% |
38,865
-2,741
| -7% | -$1.61K |
|
2046
Caribou Biosciences
CRBU
$156M
| $16.3K | ﹤0.01% |
17,810
-5,360
| -23% | -$6.97K |
|
2047
Destination XL Group
DXLG
$34.7M
| $15.9K | ﹤0.01% |
10,863
-4,228
| -28% | -$9.89K |
|
|
VTYX
2048
DELISTED
Ventyx Biosciences
VTYX
| $15.1K | ﹤0.01% |
13,156
-3,960
| -23% | -$6.8K |
|
2049
SES AI
SES
$186M
| $14.9K | ﹤0.01% |
28,697
-7,980
| -22% | -$7.34K |
|
2050
TScan Therapeutics
TCRX
$51.9M
| $14.7K | ﹤0.01% |
10,626
-2,514
| -19% | -$5.44K |
|
Similar funds
ProShare Advisors's Q1 2025 Portfolio in Review
As of Q1 2025, ProShare Advisors held 2,291 positions worth $44.3B, up 1.3% from $43.8B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
ProShare Advisors deployed $2.58B of net new capital in Q1 2025, opening 20 new positions and adding to 497 existing holdings. Its largest new stake was ManpowerGroup: 504,581 shares worth $29.2M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
On the sell side, the largest reduction was Emerson Electric, an estimated $51.8M trimmed.
- ProShare Advisors's largest Q1 2025 buy was ManpowerGroup: 504,581 shares worth $29.2M.
- ProShare Advisors added most to Apple in Q1 2025, an estimated $224M increase.
- ProShare Advisors's biggest Q1 2025 reduction was Emerson Electric, cutting an estimated $51.8M.
- ProShare Advisors fully exited Premier Financial Corp. Common Stock in Q1 2025, selling an estimated $7.12M.
- ProShare Advisors's ten largest holdings make up 27% of its $44.3B portfolio in Q1 2025.
- ProShare Advisors opened 20 new positions and closed 209 in Q1 2025.
- ProShare Advisors's portfolio value rose 1.3% quarter-over-quarter to $44.3B.
Based on ProShare Advisors's 13F filing for Q1 2025, filed 8 May 2025.